Quick Search 
Drug Data Report
Register or sign in

  
 
  
Volume 32, Issue 4, April 2010, Pages 347-448

Analgesic and Anesthetic Drugs
Full Text: PDF (68 Kb)

TREATMENT OF PAIN
679093 (CNRS;Hôpitaux de

Marseille;Université
de la Méditerranée
[Aix-Marseille II])
685585 (Neuraxon)
687253 (Purdue Pharma)
688318 (Amgen)
688891 (Concert
Pharmaceuticals)
689836 (sanofi-aventis)
690922 (Merck & Co.)

Psychopharmacologic Drugs
Full Text: PDF (118 Kb)

TREATMENT OF
SLEEP DISORDERS

687846 (Merck & Co.)

ANXIOLYTICS
686723 (Roche)
688365 (Szegedi

Tudományegyetem)
689552 (Roche)
689906 (Lundbeck)
690860 (Pfizer)

ANTIPSYCHOTIC DRUGS
688109 (Takeda)
688810 (GlaxoSmithKline)
689767 (Addex

Pharmaceuticals;
Ortho-McNeil-Janssen)
AC-260584 (ACADIA)

TREATMENT OF MOOD
DISORDERS

689472 (NeuroSearch)
690348 (XenoPort)

Neurologic Drugs
Full Text: PDF (144 Kb)

ANTIEPILEPTIC DRUGS
686544 (Janssen)
689725 (NeuroSearch)
689849 (Lectus Therapeutics)

TREATMENT OF
EXTRAPYRAMIDAL MOVEMENT
DISORDERS

687150 (Kissei)
690336 (Merck & Co.)

TREATMENT OF COGNITION DISORDERS
685564 (Janssen)
685699 (Memory

Pharmaceuticals)
686861 (CNRS)
688273 (NeuroSearch)
688277 (Vitae
Pharmaceuticals)
689006 (Memory
Pharmaceuticals)
689458 (NeuroSearch)
689636 (NeuroSearch)
689640 (Evotec
Neurosciences)
689685 (Probiodrug)
689916 (Janssen)
690012 (Pfizer)
690215 (Ligand;Merck & Co.)
Tetrahydrohyperforin (Indena)
PF-03900422 (Pfizer)
PF-04447943 (Pfizer)
PF-4181366 (Pfizer)
WAY-264116 (Pfizer)

MISCELLANEOUS
NEUROLOGIC DRUGS

ANLE-138b (Ludwig-

Maximilians-
Universität München;
Max-Planck-
Gesellschaft)
688222 (Summit)

Respiratory Drugs
Full Text: PDF (86 Kb)

ASTHMA AND COPD THERAPY
686048 (7TM Pharma)
686984 (Amira

Pharmaceuticals)
687569 (Boehringer Ingelheim)
688048 (GlaxoSmithKline)
688056 (GlaxoSmithKline)
688524 (N30 Pharma)
689476 (Boehringer Ingelheim)
689622 (Actimis
Pharmaceuticals)
689678 (Boehringer Ingelheim)

Cardiovascular Drugs
Full Text: PDF (74 Kb)

TREATMENT OF HYPERTENSION
687721 (GlaxoSmithKline)
687759 (GlaxoSmithKline)
689954 (Actelion)
MNIC+Cl– (Jagiellonian

University;Politechnika
Lódzka)

TREATMENT OF DISORDERS
OF THE CORONARY ARTERIES

689616 (Dr. Reddy's

Laboratories)
689743 (Dr. Reddy's
Laboratories)
CD31 564-574 (INSERM)

Hematologic Drugs
Full Text: PDF (82 Kb)

ANTICOAGULANTS
RWJ-671818 (Johnson

& Johnson)
TAK-442 (Takeda)

ANTIPLATELET THERAPY
689546 (LG Life Sciences)
F-16618 (Pierre Fabre)

HEMATOPOIESIS DISORDER THERAPY
688119 (CrystalGenomics)
688449 (FibroGen)
688468 (GlaxoSmithKline)
JNJ-42041935 (Johnson

& Johnson)

Gastrointestinal Drugs
Full Text: PDF (51 Kb)

ANTIULCER DRUGS
689098 (Takeda)

TREATMENT OF PANCREATIC DISORDERS
JNJ-26273364 (Johnson &

Johnson)

Endocrine Drugs
Full Text: PDF (152 Kb)

THYROID DISEASE THERAPY
676330 (Amgen)

TREATMENT OF DIABETES
AND RELATED DISEASES

432468 (Merck & Co.)
643916 (Merck & Co.)
685725 (Melior Discovery)
686120 (Theracos)
687168 (Takeda)
687258 (Kalypsys)
688225 (Merck KGaA)
688232 (Merck KGaA)
688479 (Metabasis)
688600 (Changzhou Hi-

Tech District Multiple
Dimension Industry
Techology Institute)
688716 (Banyu)
688876 (55pharma Drug
Discovery &
Development)
688881 (Banyu)
689104 (Triad Multitech
Pharmaceuticals)
689707 (Merck & Co.)
689957 (Merck & Co.)
689973 (Merck & Co.)
691487 (Roche)
PF-4620110 (Pfizer)
RO-0509727 (Roche)
RO-5312776 (Roche)

TREATMENT OF FEMALE
SEXUAL DYSFUNCTION

687668 (Pfizer)

TREATMENT OF
GYNECOLOGICAL DISORDERS

VA-111913 (Vantia)

Dermatologic Drugs
Full Text: PDF (53 Kb)

MISCELLANEOUS
DERMATOLOGIC DRUGS

689032 (Galderma)

Antiinfective Therapy
Full Text: PDF (196 Kb)

ANTIBIOTICS AND
ANTIBACTERIAL DRUGS

685378 (Ferrer)
685410 (Mutabilis)
686985 (TaiGen

Biotechnology)
687693 (GlaxoSmithKline)
687907 (Merck & Co.)
689236 (Targanta)
690939 (Taisho;Toyama)
BP-4Q-002 (MerLion
Pharmaceuticals)
PF-03315011 (Pfizer)

ANTIMYCOBACTERIAL AGENTS
I-A09 (Aarden

Pharmaceuticals;Indiana
University Research
& Technology Corp.)
KBF-611 (University of the
Sciences)

ANTIVIRAL DRUGS
685150 (Anadys)
688019 (Tibotec)
688360 (Biota Scientific

Management;
Boehringer Ingelheim)
688364 (Merck &: Co.;Southern
Research Institute)
688815 (Roche)
689647 (GlaxoSmithKline)
690899 (Merck & Co.)
Acyclovir/Hydrocortisone (Meda;
Medivir)
Alisol A Tetraacetate (Chinese
Academy of
Sciences;Takeda)
AVX-601 (AlphaVax;Novartis)
BI-201335 (Boehringer Ingelheim)
BMS-650032 (Bristol-Myers
Squibb)
CAdVax-RVF (GenPhar;University
of Texas Medical Branch
at Galveston)
FGI-103 (Department of the Army;
Functional Genetics;US
Army Medical Research
Institute of Infectious
Diseases)
M2e-HBc (sanofi-aventis;Vlaams
Interuniversitair Instituut
voor Biotechnologie)
PSI-7851 (Pharmasset;Roche)
Triazavirine (Russian Academy of
Medical Sciences;Russian
Academy of Sciences)

AIDS MEDICINES
685461 (Avexa)
SQE-95 (BioAlliance Pharma)

TREATMENT OF PROTOZOAL DISEASES
688160 (University of Cape Town)
692573 (Universiteit Antwerpen;

Swiss Tropical Institute;Ohio
State University;Ecole
Nationale Supérieure
Chimie Paris)
GLURP-MSP3 Hybrid Vaccine
(African Malaria Network
Trust;Eberhard Karls-
Universität Tübingen;
European Malaria Vaccine
Initiative;Statens Serum
Institut)

Treatment of Musculokeletal and Connective Tissue Diseases
Full Text: PDF (72 Kb)

TREATMENT OF ARTHRITIS
687259 (Pfizer)
688829 (Bracco Imaging)
689507 (Arena)
LX-2931 (Lexicon Pharmaceuticals)

Immunomodulating Agents
Full Text: PDF (81 Kb)

IMMUNOMODULATING AGENTS
687343 (BioCryst)
688824 (Bayer Schering Pharma)
688919 (CalciMedica)
689689 (CalciMedica)
689990 (Vertex)
690093 (Vertex)
D-1 (Dynavax)
GPM-1 (University of Connecticut;

Korea Research Institute of
Chemical Technology;
Seoul National University)

Treatment of Cancer
Full Text: PDF (295 Kb)

CANCER CHEMOTHERAPY
654946 (Universität des

Saarlandes)
679110 (Lexicon Pharmaceuticals)
685568 (BC Cancer Agency;
University of British
Columbia)
685765 (CNRS;Université Denis
Diderot;INSERM; Université
Pierre et Marie Curie;
Université de Rennes 1))
686298 (Myriad Pharmaceuticals)
686873 (Sentinel Oncology)
686883 (Servier)
687302 (Lixte)
687816 (Banyu;Merck & Co.)
687823 (Genentech)
687854 (LEAD Therapeutics)
687866 (Amgen)
687989 (Synta Pharmaceuticals)
688107 (Elara Pharmaceuticals;
European Molecular
Biology Laboratory)
688139 (Pfizer)
688242 (Merck KGaA)
688310 (Astex;Novartis)
688440 (Concert Pharmaceuticals)
688606 (Locus Pharmaceuticals)
688626 (Simcere Pharmaceutical)
688833 (Nerviano Medical
Sciences)
688947 (Leo)
688955 (Istituto di Ricerche di
Biologia Molecolare
P. Angeletti)
689074 (TopoTarget)
689664 (Merck Serono)
689793 (AntiCancer;Kinagen;
TargeGen)
689860 (Merck & Co.)
690308 (Auckland Uniservices)
690855 (Amgen)
690920 (Pfizer)
A-966942 (Abbott)
APR-246 (Aprea;Karolinska
Institutet)
AT-9311 (Astex;Novartis)
EMD-534085 (Merck KGaA)
GNF-5 (IRM;LLC;Novartis)
INCB-16562 (Incyte)
K-454 (Kyowa Hakko Kirin)
KU-60019 (KuDOS
Pharmaceuticals)
KYT-0353 (J-Pharma;Mitsubishi
Tanabe Pharma)
Mifamurtide (IDM;Takeda)
Nanomolide A (PharmaMar)
NSC-746366 (National Defense
Medical Center)
NV-17 (Novogen)
Hyaluronic acid-paclitaxel
bioconjugate (Fidia)
PGB2-105 (University of Central
Florida)
S-PAC-1 (University of Illinois)
Stellatolide A (PharmaMar)
TCA-001 (Cancer Research
Technology)

BIOLOGICS FOR CANCER
THERAPY

694360 (Genentech;Nerviano

Medical Sciences)
HB1.F3.Ad-H2IgG (Beckman
Research. Institute
of the City of Hope;
City of Hope National
Medical Center)
i-BD Cancer Vaccine (Dana-Farber
Cancer Institute; Harvard
College; InCytu)
IMP-321 (Immutep)
MDX-1342 (Medarex)
RO-5323441 (BioInvent;
Roche;ThromboGenics)

Ocular Medications
Full Text: PDF (76 Kb)

TREATMENT OF AGE-RELATED MACULAR DEGENERATION
687662 (NicOx)
689612 (Acucela)

MISCELLANEOUS OCULAR MEDICATIONS
691221 (Allergan)
GB-1201 (Nihon University;Roswell

Park Cancer Institute)

Metabolic Drugs
Full Text: PDF (129 Kb)

TREATMENT OF LIPOPROTEIN DISORDERS
643244 (Merck & Co.)
685544 (sanofi-aventis)

TREATMENT OF OBESITY AND NUTRITIONAL DISORDERS
684225 (7TM Pharma)
686914 (Glenmark

Pharmaceuticals)
689494 (Merck Frosst)
690343 (Pfizer)
ABD-652 (University of Aberdeen)
BAG-1 (Merck & Co.)
JNJ-16269110 (Johnson & Johnson)

THERAPY OF INBORN ERRORS
OF METABOLISM

Ecallantide (Cubist;Dyax;

sanofi-aventis)
Migalastat Hydrochloride
(Amicus Therapeutics)
Velaglucerase Alfa (Shire;Shire
Human Genetic Therapies)

Diagnostic Agents
Full Text: PDF (59 Kb)

DIAGNOSTIC AGENTS
689075 (Treventis)
692431 (Beijing Normal University)
[18F]-FP2OP (Beijing Normal

University;Capital University
of Medical Sciences;Chinese
Academy of Medical
Sciences)
[18F]FPEB (Institute for
Neurodegenerative
Disorders;Merck & Co.)
[11C]-MK-4232 (Merck & Co.)

Treatment of Pathological Processes
Full Text: PDF (66 Kb)

TREATMENT OF INFLAMMATION
667325 (Eberhard Karls-Universität

Tübingen;Universitätsklinikum
Tübingen;Friedrich-
Alexander-Universität;IRCCS
Centro Neurolesi "Bonino
Pulejo";Università degli studi
di Napoli Federico II)
686279 (Catabasis
Pharmaceuticals)
686541 (Scripps Research
Institute)
689830 (Galapagos)
690912 (Merck & Co.)

 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy